Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study to reveal hidden weaknesses in vaccines for Immune-Compromised patients

NCT ID NCT06612515

Recruiting now Knowledge-focused Sponsor: University of Cologne Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how well vaccines against respiratory viruses (like flu or COVID-19) work in people with weakened immune systems, including those with blood cancers. Researchers will measure both antibody and T cell responses after vaccination. The goal is to understand why vaccines often work less effectively in these patients and find ways to improve protection. About 1,000 adults who are either immunocompromised or have a blood cancer will participate.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IMMUNODEFICIENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

immunodeficiency disease inborn error of immunity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

IMMUNODEFICIENCY

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University Hospital Cologne

    RECRUITING

    Cologne, North Rhine-Westphalia, 50937, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••